Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Current and Future Indication for Testing and Use of Cardiac Troponin in Children.

Clinical chemistry·2026

Same author

Modifiers of the effectiveness of point-of-care troponin testing and determinants of concordance between diagnostic pathway recommendations and disposition in patients with chest pain: a post hoc analysis of a randomised controlled trial.

Emergency medicine journal : EMJ·2026

Same author

Taking assessment to the patient: can we break the emergency department gridlock?

Heart (British Cardiac Society)·2026

Same author

Evidence-based implementation of accelerated diagnostic pathway: time for a change.

Heart (British Cardiac Society)·2025

Same author

Analytical Error of Cardiac Troponin and Impact on the Performance of Accelerated Diagnostic Protocols in Patients with Acute Chest Pain.

Clinical chemistry·2025

Same author

The Dilemma of Finding a Young Patient with a Raised Cholesterol Concentration.

The journal of applied laboratory medicine·2025

Search research articles

Related Experiment Video

Updated: May 22, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Republished: Sensitive troponin assays.

Paul O Collinson¹

¹Department of Cardiology, St George's Hospital and Medical School, London SW17 0RE, UK. paul.collinson@stgeorges.nhs.uk

Postgraduate Medical Journal

|May 16, 2012

Summary

Sensitive troponin assays enable earlier myocardial infarction (MI) diagnosis, potentially within 1-3 hours. Elevated troponin levels in non-MI patients indicate poor prognosis, while normal levels suggest safe hospital discharge.

Area of Science:

Cardiology
Clinical Chemistry
Biomarker Discovery

Background:

The universal definition of myocardial infarction (MI) necessitates sensitive diagnostic tools.
Traditional troponin assays have limitations in early MI detection and prognostic assessment.

Purpose of the Study:

To evaluate the clinical utility of sensitive troponin assays for diagnosing myocardial infarction (MI).
To explore the prognostic implications of elevated troponin levels in patients without acute coronary syndromes.

Main Methods:

Utilized sensitive troponin assays with improved analytical precision below the 99th percentile.
Assessed the diagnostic accuracy of single troponin values and the rate of change (Δ troponin).
Examined the prognostic value of troponin elevation in diverse patient populations.

More Related Videos

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

Related Experiment Videos

Last Updated: May 22, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

Main Results:

Sensitive troponin assays facilitate earlier MI diagnosis, potentially within 1-3 hours of admission.
The rate of change (Δ troponin) aids in MI diagnosis.
Elevated troponin levels, even without suspected acute coronary syndromes, are associated with adverse prognosis.
Normal troponin levels indicate a good prognosis, allowing for safe early hospital discharge.

Conclusions:

Sensitive troponin assays enhance MI diagnosis and risk stratification.
Clinicians must adapt diagnostic approaches to incorporate dynamic troponin changes.
Troponin testing provides crucial prognostic information beyond acute coronary syndromes.